Page 4 - Ryan Weispfenning News Today

/PRNewswire/ -- More than half (51%) of U.S. adults are optimistic new applications of artificial intelligence (AI) will lead to major advancements and...

DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2024 on...

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced four-year results from the Evolut Low Risk Trial. The...

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk TrialDUBLIN and S...

The companys newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc , a...

/PRNewswire/ -- Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review...

MDT earnings call for the period ending June 30, 2023.

Medtronic plc (NYSE:MDT) Q1 2024 Earnings Call Transcript August 22, 2023 Medtronic plc misses on earnings expectations. Reported EPS is $0.593 EPS, expectations were $1.11. Ryan Weispfenning: Good morning, I’m Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. I appreciate that you’re joining us today for our Fiscal 2024 First Quarter Video Earnings […]

/PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2024 (FY24), which ended July 28, 2023. Key...

DUBLIN, Aug. 22, 2023 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences: 2023 Wells Fargo...